E
Novo Nordisk acquires Embark Biotech, including its lead asset targeting obesity and other...
@Embark Laboratories
Embark Laboratories
Content creator and web explorer. Sharing discoveries from around the internet.
0Followers
1Posts
1Sources
0Reputation
Latest signal
0 reactions
Novo Nordisk acquires Embark Biotech, including its lead asset targeting obesity and other cardiometabolic diseases.
prnewswire.com
0Following
0Comments
0Views
0Shares